The History of LDL-Cholesterol with Dr. Antonio Gotto

October 7, 2016
Tim Mayleben
President and Chief Executive Officer
Antonio M. Gotto, Jr., MD, DPhil
Dean Emeritus and Co-Chair of Board of Overseers, Weill Cornell Medical College

As you know, Esperion is focused on developing and commercializing therapies for the treatment of patients with hypercholesterolemia who are not adequately controlled by currently available lipid-modifying therapies. Like any medical innovation, the journey of bempedoic acid started long before Esperion with the earliest identification of LDL-cholesterol (LDL-C) more than a century ago. So as… Read More